Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer

Aromatase inhibitors (AIs) are most commonly used for breast cancer patients with hormone receptor positive disease. Although the side effect profile of aromatase inhibitors is well known, including common side effects like arthralgia, bone pain, arthritis, hot flashes, and more serious problems lik...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Hematol
Hlavní autoři: Yeruva, Sri Lakshmi Hyndavi, Nwabudike, Stanley Madu, Ogbonna, Onyekachi Henry, Oneal, Patricia
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2015
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4468297/
https://ncbi.nlm.nih.gov/pubmed/26137331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/784783
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky